Asia-Pacific Schizophrenia Drugs Market

Asia-Pacific schizophrenia drug market is estimated to grow at a CAGR of 3.6% during the forecast period. Countries in Asia-Pacific that are contributing to the market growth include China, India, and Japan. The rising healthcare expenditure of the countries along with the huge R&D investment by major pharmaceutical companies of the region is anticipated to promote the growth of the Asia-Pacific schizophrenia drug market. Further, the rising investment and initiatives from the government of various emerging economies of Asia-Pacific such as China, India, Singapore, South Korea along with many other economies towards the adoption of a healthy lifestyle tend to accelerate the market share of schizophrenia drugs in the region.

Request a free sample of our report on Asia-Pacific Schizophrenia Drugs Market: https://www.omrglobal.com/request-sample/asia-pacific-schizophrenia-drugs-market

Asia-Pacific schizophrenia drugs market is classified on the basis of therapeutic class and treatment. Based on therapeutic class, the market is segmented into second-generation antipsychotics, third-generation antipsychotics, and other therapeutic classes. Among these therapeutic classes, the second-generation antipsychotics are majorly used in therapeutic classes for the treatment of schizophrenia. Based on treatment, the market is bifurcated into oral and injectables. The oral treatment solution dominates the market due to the presence of a large number of drug manufacturing companies in the region.

A full report of Asia-Pacific Schizophrenia Drugs Market Is available at https://www.omrglobal.com/industry-reports/asia-pacific-schizophrenia-drugs-market

Asia-Pacific Schizophrenia Drugs Market Segmentation

By Therapeutic Class

• Second Generation Antipsychotics

• Third Generation Antipsychotics

• Others (First Generation Antipsychotics)

By Treatment

• Oral

• Injectables

Regional Analysis

• China

• Japan

• India

• Rest of Asia-Pacific

Company Profiles

• Alkermes PLC

• Allergan PLC

• AstraZeneca PLC

• Biogen Inc.

• Eli Lilly and Co.

• H. Lundbeck A/S

• Johnson & Johnson Services, Inc.

• Lupin Ltd.

• Merck & Co., Inc.

• Otsuka Pharmaceutical Co., Ltd.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/asia-pacific-schizophrenia-drugs-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.